These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8807719)

  • 1. Glycosaminoglycans: clinical use.
    Boneu B
    Semin Thromb Hemost; 1996; 22(2):209-12. PubMed ID: 8807719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antithrombotic agents for the prevention and treatment of deep vein thrombosis.
    Boneu B
    Haemostasis; 1996 Oct; 26 Suppl 4():368-78. PubMed ID: 8979141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low molecular weight heparins].
    Agnelli G; Cosmi B
    Medicina (Firenze); 1990; 10(1):9-15. PubMed ID: 2166209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
    Brewer D
    J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on antithrombotic agents: from unfractionated heparin to new antithrombotics.
    Agnelli G; Sonaglia F
    Haematologica; 2002 Jul; 87(7):757-70. PubMed ID: 12091128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
    Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
    Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of postoperative thrombosis with low-molecular-weight heparins].
    Jørgensen LN; Wille-Jørgensen PA; Hauch O
    Ugeskr Laeger; 1994 Sep; 156(39):5667-72. PubMed ID: 7985248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
    Hauer KE
    West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparins: are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis?
    Boneu B
    Thromb Res; 2000 Oct; 100(2):V113-20. PubMed ID: 11053624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin therapy: is monitoring needed?
    Boneu B
    Thromb Haemost; 1994 Sep; 72(3):330-4. PubMed ID: 7855780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of established venous thrombosis with low molecular weight heparins. A critical review].
    Bounameaux H
    J Mal Vasc; 1991; 16(2):129-32. PubMed ID: 1650390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
    Bendayan P; Boccalon H; Dupouy D; Boneu B
    Thromb Haemost; 1994 May; 71(5):576-80. PubMed ID: 8091383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin.
    Welzel D; Wolf H; Koppenhagen K
    Arzneimittelforschung; 1988 Jan; 38(1):120-3. PubMed ID: 2835055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin for the treatment of deep vein thrombosis.
    Thompson-Ford JK
    Pharmacotherapy; 1998; 18(4):748-58. PubMed ID: 9692649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.
    De Luca G; Marino P
    Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Hirsh J; Crowther M
    Thromb Haemost; 1997 Jul; 78(1):689-92. PubMed ID: 9198240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological actions of sulodexide.
    Ofosu FA
    Semin Thromb Hemost; 1998; 24(2):127-38. PubMed ID: 9579633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Crowther M; Hirsh J
    Semin Thromb Hemost; 1997; 23(1):77-81. PubMed ID: 9156414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.